News Category
Scinai Immunotherapeutics strengthens its CDMO platform with the appointment of Eran Kuratz, a veteran with 30 years of experience, to oversee supply ...
Quantum BioPharma announced its collaborative MS imaging study with Massachusetts General Hospital has reached midpoint enrollment, with preliminary P...
Oncotelic Therapeutics is featured in a NetworkNewsAudio editorial discussing its efforts to overcome the blood-brain barrier and its strategic moneti...
Oncotelic Therapeutics' proprietary intranasal nose-to-brain delivery platform is featured in a BioMedWire editorial, emphasizing its potential to add...
Oncotelic Therapeutics provided a corporate update on its partnership-driven strategy, highlighting a joint venture that increased its balance sheet b...
Sartorius AG's Supervisory Board extended Dr. René Faber's appointment as Executive Board member for five years until 2031, reflecting confidence in h...
Scinai Immunotherapeutics received a Nasdaq notice for non-compliance with the minimum bid price rule, with a 180-day period to regain compliance by m...
Soligenix announced that SGX945 (dusquetide) has received PIM designation from the UK MHRA for Behcet's Disease, potentially accelerating patient acce...
Silo Pharma's board has authorized a $1 million share repurchase program, signaling confidence in the company's value and providing a potential boost ...
Oncotelic Therapeutics' joint venture Sapu Nano presented data at the 2025 San Antonio Breast Cancer Symposium demonstrating that its Deciparticle nan...
Quantum BioPharma's claims of stock spoofing, part of a $700 million lawsuit against CIBC and RBC, are featured in CTV W5's second installment, unders...
